The study sought to determine long-term clinical effects of combining catheter ablation (CA) and left atrial appendage (LAA) occlusion (LAAO) in a single procedure.
(longstanding) persistent AF with remodeled and enlarged atria (6) .
Stroke is the most devastating complication of AF, accounting for 15% to 20% of all strokes (7) . According to guidelines, oral anticoagulation (OAC) is indicated to prevent thromboembolic events in patients with high stroke risk based on CHADS 2 has proven safe and successful (19) . Previously, our group has published short-term data showing that combining CA and LAAO is feasible and safe (20) . In this prospective registry study, we now show procedural data for a larger group of patients, with longterm follow-up data on bleeding, stroke, and the need for OAC. Frontiers, Inc., Carlsbad, California) as described before in detail by our group (20) (21) (22) (23) . The filter settings of the EP system (Bard, Inc., Lowell, Massachusetts) for the phased radiofrequency catheters were set from 100 to 500 kHz for the pulmonary vein (PV) ablation catheter (PVAC), with signal amplification at 5,000. PV isolation was performed with PVAC, while in patients with longstanding persistent AF complex-fractionated atrial electrogram ablation was performed with the multiarray catheters, multiarray septal catheter (septum), and multiarray ablation catheter (LA roof, free wall, mitral isthmus, mitral annulus, and posterior wall) (23) . Electrodes 1 and 10 of the PVAC were disconnected as these may induce silent cerebral ischemias by interaction. an absolute contraindication for OAC, low-molecularweight heparin was given for at least 3 weeks, as this period constitutes the highest risk period (26) . In these patients aspirin, clopidogrel, or both were also started. paroxysmal, persistent, and longstanding persistent AF, respectively) had neither documented AF recurrences nor symptoms suggestive for AF ( Table 3) . Table 3) .
Two patients died: 1 due to pneumonia with septic shock (while on aspirin) and the other due to extensive multiorgan hemorrhage resulting from RenduOsler-Weber (ROW) disease, despite not using any form of anticoagulation.
Three major bleedings were recorded in the followup period. The first patient (using aspirin) suffered major bowel bleeding caused by a carcinoma. The second (using no anticoagulation or antiplatelet drug) suffered major bowel bleeding due to ROW disease.
The third patient (using aspirin) had major recurrent lung bleeding due to pathological bronchiectasis, which had been the indication for LAAO instead of OAC in the first place.
STROKE DURING FOLLOW-UP. During follow-up, 2 patients had an episode of possible neurological symptoms that were nonwitnessed, without neurological disabilities during physical exam nor signs of neurological damage on computed tomography/ magnetic resonance ( Table 4) . Flowchart of the use of aspirin (ASA), the combination of ASA and P2Y 12 inhibitor (P2Y12-), oral anticoagulation (OAC), and novel oral anticoagulation (NOAC) in 62 patients undergoing the combined procedure before the procedure, at 3 months, and at the end of follow-up time.
Three ischemic strokes were observed during the median and mean follow-up periods of 38 Values are n (%). *Among these patients 6 used a combination of aspirin/P2Y12 inhibitor due to myocardial infarction and the rest was not on anticoagulation.
Abbreviations as in Tables 1 and 2 . In our heterogeneous study population with significant comorbidities and mean age of 68 years, embolic strokes could also have developed from noncardiac origins such as atheromatous plaque in the thoracic aorta or carotid arteries (37, 38) . Carotid artery echocardiography indeed showed plaque formation or stenosis >50% in the 3 patients that developed stroke during the follow-up period.
However, the observed annual stroke rate of 1.7% was still higher than desired after combining an ablation meant to cure AF, and adding LAAO to prevent stroke. In the 3 patients with stroke, no common explanatory denominator was apparent and their CHADS 2 score was even fairly low. AF was Alipour et al.
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CONCLUSIONS
LAAO combined with ablation for AF can be performed successfully and safely in a single procedure.
Long-term follow-up shows a lower than expected stroke rate compared to the expected baseline CHADS 2 score. However, this stroke rate is higher than desirable after combined therapy to prevent stroke at both ends. Further studies are needed to illuminate the patient phenotype, which benefits the most from the combined therapy. 
